title: Interferon-gamma-mediated activation of STAT1alpha regulates growth factor-induced mitogenesis.
abstract: Immunomodulatory cytokines and growth factors act in a complex network to regulate diverse biologic processes. Pre-treatment of two types of human vascular pericytes, liver fat-storing cells or glomerular mesangial cells, with IFN-gamma dramatically enhanced DNA synthesis in response to PDGF or EGF. IFN-gamma by itself had very little effect on DNA synthesis. At least 24-h exposure of the cells to IFN-gamma is required for enhancement of growth factor-induced mitogenesis. IFN-gamma pretreatment did not influence PDGF or EGF receptor autophosphorylation, activation of phospholipase Cgamma1, and phosphatidylinositol 3-kinase, or mitogen-activated protein kinase activity. However, IFN-gamma pretreatment markedly potentiated the DNA binding activity of STAT1alpha in response to PDGF or EGF. Incubation of cells with antisense oligonucleotides targeting STATlalpha mRNA resulted in inhibition of DNA synthesis induced by the combination of IFN-gamma and PDGF or EGF. These data indicate that interaction between IFN-gamma and growth factors at the level of STAT1alpha results in increased DNA synthesis, and establish a role for STAT1alpha in this important biologic function of growth factors.
authors.affiliation: Department of Medicine, University of Texas Health Science Center at San Antonio 78284-7882, USA.
authors.forename: F
authors.initials: F
authors.lastname: Marra
authors.forename: G G
authors.initials: GG
authors.lastname: Choudhury
authors.forename: H E
authors.initials: HE
authors.lastname: Abboud
mesh_terms: D017667:Adipocytes / Q000166:cytology; D001808:Blood Vessels / Q000166:cytology; D002455:Cell Division / Q000187:drug effects*; D002460:Cell Line; D004247:DNA / Q000096:biosynthesis; D004347:Drug Interactions; D004815:Epidermal Growth Factor / Q000494:pharmacology; D005920:Glomerular Mesangium / Q000166:cytology; D006133:Growth Substances / Q000494:pharmacology*; D006801:Humans; D050832:Interferon-Stimulated Gene Factor 3; D007371:Interferon-gamma / Q000494:pharmacology*; D008099:Liver / Q000166:cytology; D008648:Mesoderm / Q000166:cytology / Q000187:drug effects*; D016376:Oligonucleotides, Antisense / Q000494:pharmacology; D010982:Platelet-Derived Growth Factor / Q000494:pharmacology; D015398:Signal Transduction / Q000187:drug effects; D014157:Transcription Factors / Q000235:genetics / Q000378:metabolism*
chemical_list: D006133:Growth Substances; D050832:Interferon-Stimulated Gene Factor 3; D016376:Oligonucleotides, Antisense; D010982:Platelet-Derived Growth Factor; D014157:Transcription Factors; C079868:gamma interferon activation factor; D004815:Epidermal Growth Factor; D007371:Interferon-gamma; D004247:DNA